Professor and W. Eugene Stern Chair of Neurosurgery, Dr. Martin is Head of the UCLA Stroke Center and Director of the Aneurysm and AVM program. Dr. Martin specializes in the research and treatment of neurovascular disorders, including arteriovenous malformation, aneurysm and stroke.
Over the past 10 years the UCLA Neurovascular Program has become recognized as one of the leading centers in the world for the management of vascular disease of the brain and spinal cord. Over that period of time, UCLA neurovascular surgeons have collaborated with colleagues in interventional neuroradiology and stereotactic radiosurgery to treat more than 2000 patients with central nervous system vascular disorders including aneurysms, arteriovenous malformations, and carotid and intracranial atherosclerosis.
The UCLA Stroke Center which is affiliated with the Aneurysm and AVM program, teams neurosurgeons with experts in emergency neurology, cerebrovascular neurology, endovascular therapy, neuro-critical care and neurological rehabilitation. The Stroke Center has developed special programs in acute stroke response (the Brain Attack Team) and clinical stroke research. A number of groundbreaking developments in the management of patients with cerebral vascular disease originated at UCLA and were first offered to our patients: these include the GDC system (detachable coils) for aneurysm embolization, and transvenous neuroperfusion for acute stroke.
Several advanced therapeutic techniques, which are not widely available, such as extracranial-intracranial bypass, intra-operative brain mapping, and intracranial angioplasty, are employed regularly at UCLA.
The Neurovascular Surgery program is supported by on-site facilities that are equaled at very few medical centers in the world. These include:
As an academic center of excellence, we offer patients the opportunity to participate in NIH-sponsored trials of cutting-edge treatments, and are constantly in the process of analyzing our clinical results. This process, which results in publications and presentations at national and international meetings, allows us to judge clinical outcomes critically in an effort to constantly improve quality of care.
The Fantastic Voyage Of VR Health Arrives - (Forbes) April 20, 2016
A trip from a meningioma diagnose to a second life through UCLA
Membership, Medical Organizations: